Mega Nirman & Industries accepted the resignation of Anand Rai from the position of Executive Director effective August 11, 2026. The company disclosed the change in a submission to the Bombay Stock Exchange on August 20, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Rai cited personal reasons for his departure. In his resignation letter dated August 11, 2026, he confirmed there were no other material reasons for stepping down. He expressed gratitude to the Board and management for the support extended during his tenure.

The company noted that the delay in submitting the resignation letter was due to the time required for internal processes. These included verifying necessary documentation and coordinating with concerned personnel to ensure accurate disclosure. Mega Nirman stated it has taken note of the inadvertent delay to ensure timely compliance going forward.

Key Details

Kanika Chawla, Company Secretary and Compliance Officer, signed the disclosure on behalf of the company. The filing included the resignation letter and confirmed that Rai does not hold directorships in any other listed entities.

Mega Nirman & Industries Limited has formally published its unaudited standalone financial results for the quarter ended June 30, 2026, in compliance with regulatory norms. The newspaper advertisements appeared in Financial Express (English) and Jansatta (Hindi), fulfilling the disclosure obligations under Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Company Secretary and Compliance Officer, Kanika Chawla, issued the communication to BSE Limited on August 13, 2026, referencing the earlier board approval dated August 11, 2026. The financial statements, which reported a net profit of ₹2.85 lacs against a loss of ₹(18.38) lacs in the corresponding previous quarter, were reviewed by statutory auditor Krishan Rakesh & Co., Chartered Accountants.

Regulatory Compliance

The publication serves as a public record of the company’s financial performance for Q1FY26. The Board of Directors had previously approved the results during a meeting held on August 11, 2026. The statutory auditor issued an unmodified opinion on the results in their Limited Review Report, confirming compliance with Ind AS 34 and Regulation 33 of the SEBI (LODR) Regulations, 2015.

Q1FY26 Financial Performance

Total revenue for the quarter stood at ₹281.56 lacs, comprising ₹239.99 lacs from operations and ₹41.57 lacs from other income. Total expenses were contained at ₹277.75 lacs, leading to a profit before tax of ₹3.81 lacs. After accounting for current tax of ₹0.96 lacs, the company reported a net profit of ₹2.85 lacs. The following table details the key financial metrics:

Operational expenses included ₹227.22 lacs for purchases of stock-in-trade, ₹22.52 lacs for employee benefits, and ₹5.34 lacs for depreciation and amortisation. Finance costs remained low at ₹0.78 lacs. The company also recorded a net gain on equity instruments designated at FVOCI of ₹2.72 lacs.

Board Reconstitution

The board approved the appointment of Mr. Himanshu Gopal as Additional Director (Executive) and Ms. Shruti Swaroop as Independent Director, both effective August 11, 2026. Mr. Gopal, who has served as CFO since November 27, 2019, brings extensive experience in finance and taxation. Ms. Swaroop is a senior global HR and leadership advisor with over 20 years of experience in corporate governance.

Concurrently, the board accepted the resignations of Mr. Anand Rai as Executive Director and Ms. Sushma Jain as Non-Executive Independent Director, effective close of business hours on August 11, 2026. Ms. Jain cited personal reasons for her departure and confirmed no other material issues. She also holds a directorship at Beswasth Healthcare Limited.

Revised Committee Composition

Following these changes, the committee structures were updated:

• Audit Committee: Mrs. Anubha Chauhan, Ms. Shruti Swaroop (Chairperson), and Mr. Himanshu Gopal.
• Nomination and Remuneration Committee: Mrs. Anubha Chauhan, Mr. Govind Mishra, and Ms. Shruti Swaroop (Chairperson).
• Stakeholder Relationship Committee: Mrs. Anubha Chauhan (Chairperson), Ms. Shruti Swaroop, and Mr. Himanshu Gopal.

Fund Utilisation Status

The board also reviewed the Statement of Deviation under Regulation 32 of SEBI Listing Regulations. Funds raised through preferential issues allotting 2,23,00,000 equity shares (conversion of warrants) amounted to ₹25.08 Crores received during Q3FY26. These funds were allocated to working capital, and the company reported full utilisation of ₹25.08 Crores as of December 31, 2025, with no deviation or variation in the use of funds.